Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection

By Taylor N.A.   Liao Z.X.   Cox J.D.   Stevens C.   Roth J.   Walsh G.   Chang J.Y.   Guerrero T.   Jeter M.   Putnam J.   Fossella F.V.   Allen P.   Komaki R.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 204-212

Elsevier

Access to resources Recommend Favorite

Clinical observation of pemetrexed on advanced non-small-cell lung cancer

By Zheng Yongfa   Ge Wei   Zhang Ling   Zhao Zhenyu   Jie Fangfang  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 3, 2011-03 ,pp. : 140-143

Springer Publishing Company

Access to resources Recommend Favorite

The place of pemetrexed in the management of non-small-cell lung cancer patients

By Tomasini Pascale   Greillier Laurent   Khobta Nataliya   Barlesi Fabrice  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer

By Miyata Junya   Sano Takahiro   Bando Hiroyasu  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 11-14

Humana Press, Inc

Access to resources Recommend Favorite

Dose escalation study of carboplatinpemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer

By Tamiya A.   Tamiya M.   Shiroyama T.   Kanazu M.   Hirooka A.   Tsuji T.   Morishita N.   Asami K.   Suzuki H.   Okamoto N.   Okishio K.   Kawaguchi T.   Hirashima T.   Atagi S.   Kawase I.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 980-985

Oxford University Press

Access to resources Recommend Favorite